These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

340 related items for PubMed ID: 16413649

  • 1. Human reporter gene assays: transcriptional activity of the androgen receptor is modulated by the cellular environment and promoter context.
    Simon S, Mueller SO.
    Toxicology; 2006 Mar 15; 220(2-3):90-103. PubMed ID: 16413649
    [Abstract] [Full Text] [Related]

  • 2. Development of androgen- and estrogen-responsive bioassays, members of a panel of human cell line-based highly selective steroid-responsive bioassays.
    Sonneveld E, Jansen HJ, Riteco JA, Brouwer A, van der Burg B.
    Toxicol Sci; 2005 Jan 15; 83(1):136-48. PubMed ID: 15483189
    [Abstract] [Full Text] [Related]

  • 3. Sensitive in vitro test systems to determine androgenic/antiandrogenic activity.
    Guth SE, Böhm S, Mussler BH, Eisenbrand G.
    Mol Nutr Food Res; 2004 Sep 15; 48(4):282-91. PubMed ID: 15497179
    [Abstract] [Full Text] [Related]

  • 4. Androgen receptor activities of p,p'-DDE, fenvalerate and phoxim detected by androgen receptor reporter gene assay.
    Xu LC, Sun H, Chen JF, Bian Q, Song L, Wang XR.
    Toxicol Lett; 2006 Jan 05; 160(2):151-7. PubMed ID: 16125883
    [Abstract] [Full Text] [Related]

  • 5. Steroid hormonal regulation of growth, prostate specific antigen secretion, and transcription mediated by the mutated androgen receptor in CWR22Rv1 human prostate carcinoma cells.
    Attardi BJ, Burgenson J, Hild SA, Reel JR.
    Mol Cell Endocrinol; 2004 Jul 30; 222(1-2):121-32. PubMed ID: 15249132
    [Abstract] [Full Text] [Related]

  • 6. Suppression of mutant androgen receptors by flutamide.
    Ishioka J, Hara S, Isaacs JT, Tomura A, Nishikawa K, Kageyama Y.
    Int J Urol; 2009 May 30; 16(5):516-21. PubMed ID: 19389135
    [Abstract] [Full Text] [Related]

  • 7. Decoy androgen-responsive element DNA can inhibit androgen receptor transactivation of the PSA promoter gene.
    Zhang P, Zhang J, Young CY, Kao PC, Chen W, Jiang A, Zhang L, Guo Q.
    Ann Clin Lab Sci; 2005 May 30; 35(3):278-84. PubMed ID: 16081584
    [Abstract] [Full Text] [Related]

  • 8. Optimization and prevalidation of the in vitro AR CALUX method to test androgenic and antiandrogenic activity of compounds.
    van der Burg B, Winter R, Man HY, Vangenechten C, Berckmans P, Weimer M, Witters H, van der Linden S.
    Reprod Toxicol; 2010 Aug 30; 30(1):18-24. PubMed ID: 20438827
    [Abstract] [Full Text] [Related]

  • 9. Methoxyacetic acid disregulation of androgen receptor and androgen-binding protein expression in adult rat testis.
    Tirado OM, Martinez ED, Rodriguez OC, Danielsen M, Selva DM, Reventós J, Munell F, Suárez-Quian CA.
    Biol Reprod; 2003 Apr 30; 68(4):1437-46. PubMed ID: 12606434
    [Abstract] [Full Text] [Related]

  • 10. Antiandrogenic activity of norgestimate in a human androgen-dependent stable-transfected cell line.
    Paris F, Rabeolina F, Balaguer P, Bacquet A, Sultan C.
    Gynecol Endocrinol; 2007 Apr 30; 23(4):193-7. PubMed ID: 17505938
    [Abstract] [Full Text] [Related]

  • 11. Development of an androgen reporter gene assay (AR-LUX) utilizing a human cell line with an endogenously regulated androgen receptor.
    Blankvoort BM, de Groene EM, van Meeteren-Kreikamp AP, Witkamp RF, Rodenburg RJ, Aarts JM.
    Anal Biochem; 2001 Nov 01; 298(1):93-102. PubMed ID: 11673900
    [Abstract] [Full Text] [Related]

  • 12. Partial agonist/antagonist properties of androstenedione and 4-androsten-3beta,17beta-diol.
    Chen F, Knecht K, Leu C, Rutledge SJ, Scafonas A, Gambone C, Vogel R, Zhang H, Kasparcova V, Bai C, Harada S, Schmidt A, Reszka A, Freedman L.
    J Steroid Biochem Mol Biol; 2004 Aug 01; 91(4-5):247-57. PubMed ID: 15336702
    [Abstract] [Full Text] [Related]

  • 13. Prosaposin upregulates AR and PSA expression and activity in prostate cancer cells (LNCaP).
    Koochekpour S, Lee TJ, Wang R, Culig Z, Delorme N, Caffey S, Marrero L, Aguirre J.
    Prostate; 2007 Feb 01; 67(2):178-89. PubMed ID: 17044040
    [Abstract] [Full Text] [Related]

  • 14. Screening of some anti-androgenic endocrine disruptors using a recombinant cell-based in vitro bioassay.
    Roy P, Salminen H, Koskimies P, Simola J, Smeds A, Saukko P, Huhtaniemi IT.
    J Steroid Biochem Mol Biol; 2004 Feb 01; 88(2):157-66. PubMed ID: 15084347
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Androgen responsiveness of Renilla luciferase reporter vectors is promoter, transgene, and cell line dependent.
    Mulholland DJ, Cox M, Read J, Rennie P, Nelson C.
    Prostate; 2004 May 01; 59(2):115-9. PubMed ID: 15042611
    [Abstract] [Full Text] [Related]

  • 18. Oestrogenic and androgenic activity of triclosan in breast cancer cells.
    Gee RH, Charles A, Taylor N, Darbre PD.
    J Appl Toxicol; 2008 Jan 01; 28(1):78-91. PubMed ID: 17992702
    [Abstract] [Full Text] [Related]

  • 19. Comparison of chromatin remodeling and transcriptional activation of the mouse mammary tumor virus promoter by the androgen and glucocorticoid receptor.
    List HJ, Lozano C, Lu J, Danielsen M, Wellstein A, Riegel AT.
    Exp Cell Res; 1999 Aug 01; 250(2):414-22. PubMed ID: 10413595
    [Abstract] [Full Text] [Related]

  • 20. Screening for (anti)androgenic properties using a standard operation protocol based on the human stably transfected androgen sensitive PALM cell line. First steps towards validation.
    Freyberger A, Witters H, Weimer M, Lofink W, Berckmans P, Ahr HJ.
    Reprod Toxicol; 2010 Aug 01; 30(1):9-17. PubMed ID: 19836445
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.